Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Late Quaternary climate impact on the genome of the woodland strawberry (Fragaria vesca), a perennial herb.

Communications biology·2026
Same author

Developmental processes in the Rosaceae through the lens of DNA and RNA methylation.

Planta·2025
Same author

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Genomic selection strategies for clonally propagated crops.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2023
Same author

High-Density Linkage Map Construction and QTL Identification in a Diploid Blueberry Mapping Population.

Frontiers in plant science·2021
Same author

Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials.

JCO precision oncology·2020

Related Experiment Video

Updated: Jun 1, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Meta-analysis for surrogacy: accelerated failure time models and semicompeting risks modeling.

Debashis Ghosh1, Jeremy M G Taylor, Daniel J Sargent

  • 1Department of Statistics, The Pennsylvania State University, University Park, Pennsylvania 16802, USA. ghoshd@psu.edu

Biometrics
|June 15, 2011
PubMed
Summary

This study introduces new statistical methods using accelerated failure time models to validate surrogate endpoints in medical research. These methods improve the assessment of surrogacy, especially in complex semicompeting risks scenarios.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

Related Experiment Videos

Last Updated: Jun 1, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Medical Research Methodology

Background:

  • Growing interest in validating surrogate endpoints as proxies for clinical outcomes.
  • Increasing use of meta-analytical methods for quantifying surrogacy.
  • Need for robust statistical approaches in medical studies.

Purpose of the Study:

  • To extend accelerated failure time (AFT) models for surrogate endpoint validation.
  • To develop methods for semicompending risks settings, modeling surrogate events preceding true endpoints.
  • To introduce novel procedures for quantifying both between- and within-trial surrogacy.

Main Methods:

  • Application of accelerated failure time models.
  • Development of estimation and inferential procedures for surrogacy.
  • Introduction of between- and within-trial evaluation methods.
  • Novel principal components procedure for trial-level surrogacy quantification.

Main Results:

  • Extended AFT model procedures to the quantification of surrogacy.
  • Enabled analysis in semicompeting risks settings.
  • Developed novel methods for evaluating trial-level surrogacy.
  • Illustrated methods with colorectal cancer study data.

Conclusions:

  • Accelerated failure time models offer advantages for surrogate endpoint validation, particularly in semicompeting risks.
  • New statistical procedures enhance the quantification and evaluation of surrogacy at both individual and trial levels.
  • The developed methods provide valuable tools for medical research, exemplified by colorectal cancer studies.